期刊文献+

D-(-)-α-磺苄西林钠的合成工艺改进 被引量:2

Improved synthesis of optical active D-(-)-α-sulbenicillin disodium
原文传递
导出
摘要 目的改进D-(-)-α-磺苄西林钠的合成工艺。方法以苯乙酸为起始原料,经磺化、碱化、离子交换后得消旋的磺苯乙酸,制得磺苯乙酰氯后,与6-APA缩合得到磺苄西林的非对映异构体。通过重结晶的方法分离出D-(-)-α-磺苄西林,再与异辛酸钠成盐制得目标化合物。结果及结论成功地制备了D-(-)-α-磺苄西林钠,缩短了合成路线并节约了成本,更利于工业化生产。 OBJECTIVE To modify the process to synthesize optical active D-(-)-α-sulbenicillin disodium.METHODS The racemic α-sulfophenylacetate was obtained by sulfonation,alkalization and ion exchange of the starting material phenylacetic acid.After the compound was transferred to α-sulfophenylacetyl chloride,the racemic sulbenicillin was produced by condenscition with 6-APA.By the means of recrystallization,the optical active D-(-)-α-sulbenicillin was separated.Finally,the targeting compound D-(-)-α-sulbenicillin disodium was obtained following treatment by sodium iso-octoate.RESULTS and CONCLUSION The targeting compound D-(-)-α-sulbenicillin disodium was successfully synthesized.This synthesis progress is simple,low-cost and easy for industrial production.
出处 《华西药学杂志》 CAS CSCD 北大核心 2011年第4期313-315,共3页 West China Journal of Pharmaceutical Sciences
关键词 磺苄西林钠 光学活性 工艺改进 Sulbenicillin disodium Optical activity Synthetic improvement
  • 相关文献

参考文献6

  • 1Aronson JK. Side effects of drugs annual [ M ]. Netherlands: Elsevier Science ,2001,24:273 - 282.
  • 2宗志勇.新抗铜绿假单胞菌药的研究开发进展[J].国外医药(抗生素分册),2002,23(1):23-26. 被引量:2
  • 3Morimoto S, Nomura H, Ishiguro T, et al. Semisynthetic β- lactam antibiotics. 1. acylation of 6 - aminopenicillanic acid with activated derivatives of ctsulfophenylacetic acid [ J ]. J Med Chem, 1972, 15(11): 1105-1108.
  • 4Morimoto S, Nomura H, Fugono T, et al. Semisynthetic β-lactam antibiotics. 2. synthesis and properties of D - and L - ctsulfo- benzylpenicillins [ J]. J Med Chem, 1972,15 ( 11 ) : 1108 - 1111.
  • 5夏莘强 王清福 潘翠城.等半合成青霉素L旋光性a-磺苄青霉素合成的改进.中国抗生素杂志,1981,:23-24.
  • 6向红琳,谭转云,杨小红.磺苄西林钠的合成工艺改进[J].中国药科大学学报,2007,38(6):496-498. 被引量:4

二级参考文献32

  • 1Best DJ,Burton G,Davies DT,et al. Structure-activity relationships of some arylglycine analogues and catechol isosteres of BRL36650, a 6 alpha-formamido penicillin. [J]. J Antibiot, 1990,43:574
  • 2Toyosawa T, Miyazaki S, Tsuji A, et al. In vitro and in vivo antibacterial activities of E1077, a novel parenteral cephalosporin. [J]. Antimicrob Agents Chemother, 1993, 37: 60
  • 3Watanabe N, Hiruma R, Katsu K. Comparative in-vitro activities of newer cephalosporins cefclidin, cefepime, and cefpirome against ceftazidime- or imipenem-resistant Pseudomonas aeruginosa. [J]. J Antimicrob Chemother, 1992, 30: 633
  • 4Erwin ME, Jones RN, Barrett MS,et al. In vitro evaluation of GR69153, a novel catechol-substituted cephalospoin. [J]. Antimicrob Agents Chemother, 1991, 35: 929
  • 5Kim MY, Oh JI, Pack KS, et al. In vitro and in vivo activities of LB10522, a new catecholic cephalosporin. [J]. Antimicrob Agents Chemother, 1996, 40: 1825
  • 6Qadri SM, Ayub A, Ueno Y, et al. Comparative in vitro activity of Ro 09-1428, a novel cephalosporin with a catechol moiety. I-J]. Clin Ther,1992,14:562
  • 7Erwin ME, Varnam D, Jones RN. In vitro antimicrobial activity of RU-59863, a C-7 catechol substituted cephalosporin. [J]. Diagn Microbiol Infect Dis, 1997, 28: 93
  • 8Chen HY, Livermore DM. In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms. [J]. J Antimicrob Chemother, 1994, 33: 949
  • 9Kato Y, Otsuki M, Nisbino T. Antibacterial properties of BO-2727, a new carbapenem antibiotic. [J]. J Antimicrob Chemother, 1997,40:195
  • 10Tsuji M, Ishii Y, Ohno A, et al. In vitro and in vivo antibacterial activities of S-4661, a new carbapenem. [J]. Antimicrob Agents Chemother, 1998, 42: 94

共引文献4

同被引文献9

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部